Most Recent
Class action seeks evidence from jailed Crown Resorts employees
The law firm leading a shareholder class action against Crown Resorts wants evidence from employees whose arrest in China during a 2016 government crackdown on gambling sent the company's stock price tumbling.
Hytera asks to keep China’s state secrets from Motorola in IP war
Hytera Communications wants the Federal Court to block Motorola from accessing evidence in their patent war covered by Chinese laws prohibiting disclosure of state secrets or compromising the country's cybersecurity.
Gold Coast financial adviser loses defamation case over online comments
A Gold Coast-based derivatives trading firm has lost a defamation case against an online investment forum over critical comments warning potential investors against using the company.
Broker can’t take back admission in Provident class action defence
A judge has shot down a last minute bid by an insurance brokerage facing a cross claim in a class action over failed debenture issuer Provident Capital to retract an admission in its defence ahead of trial next month.
Alphapharm can’t get docs ahead of hearing on injector pen injunction
Generic drug company Alphapharm has lost a bid for documents it claimed would show Sanofi-Aventis suspected as early as 2015 that patents for one of its injector pens may be invalid.
Hytera must tell Motorola which docs blocked by Chinese cybersecurity laws
Hytera Communications has until Thursday to reveal what evidence has been or will be withheld from Motorola in their intellectually property battle in compliance with strict Chinese state security and cybersecurity laws.
ABC, Fairfax to fight dismissal of truth defence in Chau Chak Wing defamation suit
The ABC and Fairfax Media are appealing a ruling tossing their truth defence in a case brought by Chinese billionaire and philanthropist Dr Chau Chak Wing.
Motorola says Hytera misled court, wins discovery request
Motorola Solutions says Hytera Communications misled the Federal Court about key decision makers involved in the development of radio products which it claims infringe three of its patents.
Cryosite hits back at ACCC ‘gun jumping’ claims
Biologics company Cryosite has denied claims by the ACCC that it engaged in cartel conduct by referring customers to Cell Care before their asset sale agreement was completed, saying the two were not competitors.
Inhibox maker used Allergan’s Botox trade mark for comparison’s sake, court hears
The company that manufactures Botox alternatives has denied infringing on Allergan's Botox trade mark, telling a court Wednesday its use of the word was for comparative purposes only.